Home » Topics » BioWorld Science

BioWorld Science
RSS

Predicting chemotherapy synergies

Aug. 1, 2018

HSP27 found as a potential therapeutic target for treating VCID

July 31, 2018

European Commission approves Aimovig to prevent migraines

July 31, 2018

Phase II study of laquinimod in Huntington's disease does not meet primary endpoint

July 31, 2018

Regeneus reports promising first-in-human data for autologous tumor vaccine RGSH-4-K

July 31, 2018

Immutep to begin phase II study of eftilagimod alfa with pembrolizumab

July 31, 2018

ASTRAL-1 study of guadecitabine in AML does not meet coprimary endpoints

July 31, 2018

Contactin-2 levels are altered in mild cognitive impairment

July 31, 2018

Stop-gain variant in GMIP gene tied to Alzheimer's disease pathogenesis

July 31, 2018

Arcus cleared to begin phase I trial of anti-TIGIT antibody AB-154

July 31, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...